<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Ximelagatran</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Ximelagatran">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Ximelagatran</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Ximelagatran</b> (<b>Exanta</b> or <b>Exarta</b>, H 376/95) is an anticoagulant that has been investigated extensively as a replacement for <a href="Warfarin.htm" tppabs="https://ptable.com/wiki/compounds/A/Warfarin" title="Warfarin">warfarin</a><span class="mw-ref" id="cite_ref-1"><a href="#cite_note-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> that would overcome the problematic dietary, drug interaction, and monitoring issues associated with warfarin therapy. In 2006, its manufacturer AstraZeneca announced that it would withdraw pending applications for marketing approval after reports of hepatotoxicity (liver damage) during trials, and discontinue its distribution in countries where the drug had been approved (Germany, Portugal, Sweden, Finland, Norway, Iceland, Austria, Denmark, France, Switzerland, Argentina and Brazil).<span class="mw-ref" id="cite_ref-az_2-0"><a href="#cite_note-az-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>

<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Ximelagatran</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Ximelagatran.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Ximelagatran.svg.png" data-file-width="582" data-file-height="483" data-file-type="drawing" height="191" width="230"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Exanta</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">

<ul><li>Uncategorized</li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>Oral (tablets)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>B01AE05<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=B01AE05  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=B01AE05'" tppabs="https://www.whocc.no/atc_ddd_index/?code=B01AE05" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li>Withdrawn from market</li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>20%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>to melagatran</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>3–5 hours</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Renal (80%)</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">ethyl 2-[[(1<i>R</i>)-1-cyclohexyl-2-<br>[(2<i>S</i>)-2-[[4-(<i>N'</i>-hydroxycarbamimidoyl)<br>phenyl]methylcarbamoyl]azetidin-1-yl]-<br>2-oxo-ethyl]amino]acetate</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=192939-46-1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=192939-46-1'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=192939-46-1" class="external text external">192939-46-1</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/9574101  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/9574101'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/9574101" class="external text external">9574101</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6381  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6381'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6381" class="external text external">6381</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB04898  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB04898'" tppabs="https://www.drugbank.ca/drugs/DB04898" class="external text external">DB04898</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.7848559.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.7848559.html'" tppabs="http://www.chemspider.com/Chemical-Structure.7848559.html" class="external text external">7848559</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=49HFB70472  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=49HFB70472'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=49HFB70472" class="external text external">49HFB70472</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D01981  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D01981'" tppabs="https://www.kegg.jp/entry/D01981" class="external text external">D01981</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL522038  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL522038'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL522038" class="external text external">ChEMBL522038</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID5049075  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID5049075'" tppabs="https://comptox.epa.gov/dashboard/DTXSID5049075" class="external text external">DTXSID5049075</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>24</sub><span>H</span><sub>35</sub><span>N</span><sub>5</sub><span>O</span><sub>5</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">473.574</span><span>&nbsp;</span>g·mol<sup>−1</sup><span> </span>(429 g/mol after conversion)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28NCc1ccc%28C%28%3DN%5CO%29%5CN%29cc1%29%5BC%40H%5D3N%28C%28%3DO%29%5BC%40H%5D%28NCC%28%3DO%29OCC%29C2CCCCC2%29CC3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28NCc1ccc%28C%28%3DN%5CO%29%5CN%29cc1%29%5BC%40H%5D3N%28C%28%3DO%29%5BC%40H%5D%28NCC%28%3DO%29OCC%29C2CCCCC2%29CC3'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28NCc1ccc%28C%28%3DN%5CO%29%5CN%29cc1%29%5BC%40H%5D3N%28C%28%3DO%29%5BC%40H%5D%28NCC%28%3DO%29OCC%29C2CCCCC2%29CC3" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">O=C(NCc1ccc(C(=N\O)\N)cc1)[C@H]3N(C(=O)[C@H](NCC(=O)OCC)C2CCCCC2)CC3</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C24H35N5O5/c1-2-34-20(30)15-26-21(17-6-4-3-5-7-17)24(32)29-13-12-19(29)23(31)27-14-16-8-10-18(11-9-16)22(25)28-33/h8-11,17,19,21,26,33H,2-7,12-15H2,1H3,(H2,25,28)(H,27,31)/t19-,21+/m0/s1<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:ZXIBCJHYVWYIKI-PZJWPPBQSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><sup><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup><span>&nbsp;</span>(what is this?)</span><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=470633864&page2=Ximelagatran  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=470633864&page2=Ximelagatran'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=470633864&page2=Ximelagatran" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Method_of_action">Method of action</h2></summary>
    
<p>Ximelagatran, a direct thrombin inhibitor,<span class="mw-ref" id="cite_ref-pmid17319469_3-0"><a href="#cite_note-pmid17319469-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> was the first member of this class that can be taken orally. It acts solely by inhibiting the actions of <a href="Thrombin.htm" tppabs="https://ptable.com/wiki/compounds/A/Thrombin" title="Thrombin">thrombin</a>. It is taken orally twice daily, and rapidly absorbed by the small intestine. Ximelagatran is a prodrug, being converted <i>in vivo</i> to the active agent melagatran. This conversion takes place in the liver and many other tissues through hydrolysis and dehydroxylation (replacing the <a href="Ethyl_group.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethyl_group" title="Ethyl group">ethyl</a> and hydroxyl groups with <a href="Hydrogen.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydrogen" title="Hydrogen">hydrogen</a>).</p>

<div class="thumb tleft"><div class="thumbinner" style="width:332px"><img src="../I/m/Ximelagatran_activation.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Ximelagatran_activation.svg.png" data-file-width="1441" data-file-height="483" data-file-type="drawing" height="111" width="330"><div class="thumbcaption" style="text-align: left">The conversion of ximelagatran to melagatran. This conversion includes dealkylation and dehydroxylation.</div></div></div>
<div style="clear:left;"></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Uses">Uses</h2></summary>
    
<p>Ximelagatran was expected to replace <a href="Warfarin.htm" tppabs="https://ptable.com/wiki/compounds/A/Warfarin" title="Warfarin">warfarin</a> and sometimes <a href="Aspirin.htm" tppabs="https://ptable.com/wiki/compounds/A/Aspirin" title="Aspirin">aspirin</a> and <a href="Heparin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heparin" title="Heparin">heparin</a> in many therapeutic settings, including deep venous thrombosis, prevention of secondary venous thromboembolism and complications of atrial fibrillation such as stroke. The efficacy of ximelagatran for these indications had been well documented,<span class="mw-ref" id="cite_ref-4"><a href="#cite_note-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-5"><a href="#cite_note-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span><span class="mw-ref" id="cite_ref-6"><a href="#cite_note-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> except for non valvular atrial fibrillation.</p>

<p>An advantage, according to early reports by its manufacturer, was that it could be taken orally without any monitoring of its anticoagulant properties. This would have set it apart from <a href="Warfarin.htm" tppabs="https://ptable.com/wiki/compounds/A/Warfarin" title="Warfarin">warfarin</a> and <a href="Heparin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heparin" title="Heparin">heparin</a>, which require monitoring of the international normalized ratio (INR) and the partial thromboplastin time (PTT), respectively. A disadvantage recognised early was the absence of an antidote in case acute bleeding develops, while warfarin can be antagonised by prothrombin complex concentrate and/or <a href="Vitamin_K.htm" tppabs="https://ptable.com/wiki/compounds/A/Vitamin_K" title="Vitamin K">vitamin K</a> and heparin by protamine sulfate.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Side_effects">Side effects</h2></summary>
    
<p>Ximelagatran was generally well tolerated in the trial populations, but a small proportion (5-6%) developed elevated liver enzyme levels, which prompted the FDA to reject an initial application for approval in 2004. The further development was discontinued in 2006 following reports of hepatotoxicity. Subsequent analysis of Phase 2 clinical study data using extreme value modelling (see Extreme value theory) showed that the elevated liver enzyme levels observed in Phase 3 clinical studies could have been predicted; if this had been known at the time, it might have affected decisions on future development of the compound.<span class="mw-ref" id="cite_ref-Southworth_2014_7-0"><a href="#cite_note-Southworth_2014-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>

<p>A chemically different but pharmacologically similar substance, AZD0837, was developed by Aztrazeneca for similar indications.<span class="mw-ref" id="cite_ref-az_2-1"><a href="#cite_note-az-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> It is the prodrug of a potent, competitive, reversible inhibitor of free and fibrin-bound thrombin called ARH0637 <span class="mw-ref" id="cite_ref-Ahrens_8-0"><a href="#cite_note-Ahrens-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span>. The development of AZD 0837 has been discontinued. Due to a limitation identified in long-term stability of the extended-release AZD0837 drug product, a follow-up study from ASSURE on stroke prevention in patients with non-valvular atrial fibrillation, was prematurely closed in 2010 after 2 years. There was also a numerically higher mortality against warfarin. <span class="mw-ref" id="cite_ref-9"><a href="#cite_note-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span><span class="mw-ref" id="cite_ref-10"><a href="#cite_note-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-11"><a href="#cite_note-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> In a Phase 2 trial for AF the mean serum creatinine concentration increased by about 10% from baseline in patients treated with AZD0837, which returned to baseline after cessation of therapy.<span class="mw-ref" id="cite_ref-pmid19690349_12-0"><a href="#cite_note-pmid19690349-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist columns references-column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;">
<ol class="mw-references references"><li id="cite_note-1"> <span id="mw-reference-text-cite_note-1" class="mw-reference-text"><cite id="CITEREFHirshO'DonnellEikelboom2007" class="citation journal cs1">Hirsh J, O'Donnell M, Eikelboom JW (July 2007). <a href="javascript:if(confirm('http://circ.ahajournals.org/cgi/content/full/116/5/552  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://circ.ahajournals.org/cgi/content/full/116/5/552'" tppabs="http://circ.ahajournals.org/cgi/content/full/116/5/552" class="external text external">"Beyond unfractionated heparin and warfarin: current and future advances"</a>. <i>Circulation</i>. <b>116</b> (5): 552–560. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1161%2FCIRCULATIONAHA.106.685974  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1161%2FCIRCULATIONAHA.106.685974'" tppabs="https://doi.org/10.1161%2FCIRCULATIONAHA.106.685974" class="external text external">10.1161/CIRCULATIONAHA.106.685974</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17664384  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17664384'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17664384" class="external text external">17664384</a>.</cite></span></li><li id="cite_note-az-2"> <span id="mw-reference-text-cite_note-az-2" class="mw-reference-text"><cite class="citation pressrelease cs1"><a href="javascript:if(confirm('http://www.astrazeneca.com/Media/Press-releases/Article/20060214--AstraZeneca-Decides-to-Withdraw-Exanta  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.astrazeneca.com/Media/Press-releases/Article/20060214--AstraZeneca-Decides-to-Withdraw-Exanta'" tppabs="http://www.astrazeneca.com/Media/Press-releases/Article/20060214--AstraZeneca-Decides-to-Withdraw-Exanta" class="external text external">"AstraZeneca Decides to Withdraw Exanta"</a> (Press release). AstraZeneca. February 14, 2006<span class="reference-accessdate">. Retrieved <span class="nowrap">2012-07-16</span></span>.</cite></span></li><li id="cite_note-pmid17319469-3"> <span id="mw-reference-text-cite_note-pmid17319469-3" class="mw-reference-text"><cite id="CITEREFHoBrighton2006" class="citation journal cs1">Ho SJ, Brighton TA (2006). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993972  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993972'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993972" class="external text external">"Ximelagatran: direct thrombin inhibitor"</a>. <i>Vasc Health Risk Manag</i>. <b>2</b> (1): 49–58. doi:<a href="javascript:if(confirm('https://doi.org/10.2147%2Fvhrm.2006.2.1.49  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2147%2Fvhrm.2006.2.1.49'" tppabs="https://doi.org/10.2147%2Fvhrm.2006.2.1.49" class="external text external">10.2147/vhrm.2006.2.1.49</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993972  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993972'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993972" class="external text external">1993972</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17319469  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17319469'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17319469" class="external text external">17319469</a>.</cite></span></li><li id="cite_note-4"> <span id="mw-reference-text-cite_note-4" class="mw-reference-text"><cite id="CITEREFErikssonWahlander_KGustafsson_DWelin_LT2003" class="citation journal cs1">Eriksson, H; Wahlander K; Gustafsson D; Welin LT; Frison L; Schulman S; THRIVE Investigators (January 2003). "A randomized, controlled, dose-guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE I". <i>Journal of Thrombosis and Haemostasis</i>. <b>1</b> (1): 41–47. doi:<a href="javascript:if(confirm('https://doi.org/10.1046%2Fj.1538-7836.2003.00034.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1046%2Fj.1538-7836.2003.00034.x'" tppabs="https://doi.org/10.1046%2Fj.1538-7836.2003.00034.x" class="external text external">10.1046/j.1538-7836.2003.00034.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12871538  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12871538'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12871538" class="external text external">12871538</a>.</cite></span></li><li id="cite_note-5"> <span id="mw-reference-text-cite_note-5" class="mw-reference-text"><cite id="CITEREFFrancisBerkowitzCompLieberman2003" class="citation journal cs1">Francis CW, Berkowitz SD, Comp PC, Lieberman JR, Ginsberg JS, Paiement G, Peters GR, Roth AW, McElhattan J, Colwell CW Jr, EXULT A Study Group (October 2003). "Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement". <i>New England Journal of Medicine</i>. <b>349</b> (18): 1703–1712. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJMoa035162  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJMoa035162'" tppabs="https://doi.org/10.1056%2FNEJMoa035162" class="external text external">10.1056/NEJMoa035162</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14585938  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14585938'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14585938" class="external text external">14585938</a>.</cite></span></li><li id="cite_note-6"> <span id="mw-reference-text-cite_note-6" class="mw-reference-text"><cite id="CITEREFSchulmanWåhlander_KLundström_TClason_SB2003" class="citation journal cs1">Schulman, S; Wåhlander K; Lundström T; Clason SB; Eriksson H; THRIVE III investigators (October 2003). "Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran". <i>New England Journal of Medicine</i>. <b>349</b> (18): 1713–1721. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJMoa030104  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJMoa030104'" tppabs="https://doi.org/10.1056%2FNEJMoa030104" class="external text external">10.1056/NEJMoa030104</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14585939  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14585939'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14585939" class="external text external">14585939</a>.</cite></span></li><li id="cite_note-Southworth_2014-7"> <span id="mw-reference-text-cite_note-Southworth_2014-7" class="mw-reference-text"><cite id="Southworth_2014" class="citation journal cs1">Southworth, Harry (30 Jul 2014). "Predicting potential liver toxicity from phase 2 data: a case study with ximelagatran". <i>Statistics in Medicine</i>. <b>33</b> (17): 2914–2923. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fsim.6142  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fsim.6142'" tppabs="https://doi.org/10.1002%2Fsim.6142" class="external text external">10.1002/sim.6142</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24623062  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24623062'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24623062" class="external text external">24623062</a>.</cite></span></li><li id="cite_note-Ahrens-8"> <span id="mw-reference-text-cite_note-Ahrens-8" class="mw-reference-text"><cite id="CITEREFAhrensKarlheinz_PeterGregory_Y.H._LipChristoph_Bode2012" class="citation journal cs1">Ahrens, Ingo; Karlheinz Peter; Gregory Y.H. Lip; Christoph Bode (2012). "Development and Clinical Applications of Novel Oral Anticoagulants. Part II. Drugs Under Clinical Investigation". <i>Discovery Medicine</i>. <b>13</b> (73): 445–450.</cite></span></li><li id="cite_note-9"> <span id="mw-reference-text-cite_note-9" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.astrazenecaclinicaltrials.com/other-drug-products/in_development_drugs/AZD0837/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.astrazenecaclinicaltrials.com/other-drug-products/in_development_drugs/AZD0837/'" tppabs="http://www.astrazenecaclinicaltrials.com/other-drug-products/in_development_drugs/AZD0837/" class="external text external">"AZD0837"</a>. Astrazenecaclinicaltrials.com<span class="reference-accessdate">. Retrieved <span class="nowrap">2012-10-16</span></span>.</cite></span></li><li id="cite_note-10"> <span id="mw-reference-text-cite_note-10" class="mw-reference-text">AstraZeneca Long-term treatment with the oral direct thrombin inhibitor AZD0837, compared to Vitamin-K antagonists, as stroke prevention in patients with non-valvular atrial fibrillation and one or more risk factors for stroke and systemic embolic events. A 5-year follow-up study study code D1250C0004221 January 2010 <a href="javascript:if(confirm('http://www.astrazenecaclinicaltrials.com/_mshost800325/content/clinical-trials/resources/pdf/D1250C00042  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.astrazenecaclinicaltrials.com/_mshost800325/content/clinical-trials/resources/pdf/D1250C00042'" tppabs="http://www.astrazenecaclinicaltrials.com/_mshost800325/content/clinical-trials/resources/pdf/D1250C00042" class="external text external">Trial D1250C00042</a> <a href="javascript:if(confirm('https://web.archive.org/web/20131110014536/http://www.astrazenecaclinicaltrials.com/_mshost800325/content/clinical-trials/resources/pdf/D1250C00042  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20131110014536/http://www.astrazenecaclinicaltrials.com/_mshost800325/content/clinical-trials/resources/pdf/D1250C00042'" tppabs="https://web.archive.org/web/20131110014536/http://www.astrazenecaclinicaltrials.com/_mshost800325/content/clinical-trials/resources/pdf/D1250C00042" class="external text external">Archived</a><span> November 10, 2013, at the </span>Wayback Machine</span></li><li id="cite_note-11"> <span id="mw-reference-text-cite_note-11" class="mw-reference-text"><cite id="CITEREFEikelboomWeitz2010" class="citation journal cs1">Eikelboom JW, Weitz JI (2010). <a href="javascript:if(confirm('https://doi.org/10.1161/CIRCULATIONAHA.109.853119  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1161/CIRCULATIONAHA.109.853119'" tppabs="https://doi.org/10.1161/CIRCULATIONAHA.109.853119" class="external text external">"Update on Antithrombotic Therapy: New Anticoagulants"</a>. <i>Circulation</i>. <b>121</b> (13): 1523–32. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1161%2FCIRCULATIONAHA.109.853119  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1161%2FCIRCULATIONAHA.109.853119'" tppabs="https://doi.org/10.1161%2FCIRCULATIONAHA.109.853119" class="external text external">10.1161/CIRCULATIONAHA.109.853119</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20368532  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20368532'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20368532" class="external text external">20368532</a>.</cite></span></li><li id="cite_note-pmid19690349-12"> <span id="mw-reference-text-cite_note-pmid19690349-12" class="mw-reference-text"><cite id="CITEREFLipRasmussenOlssonJensen2009" class="citation journal cs1">Lip GY, Rasmussen LH, Olsson SB, Jensen EC, Persson AL, Eriksson U, Wåhlander KF (December 2009). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2785945  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2785945'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2785945" class="external text external">"Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists"</a>. <i>Eur. Heart J</i>. <b>30</b> (23): 2897–907. doi:<a href="javascript:if(confirm('https://doi.org/10.1093%2Feurheartj%2Fehp318  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Feurheartj%2Fehp318'" tppabs="https://doi.org/10.1093%2Feurheartj%2Fehp318" class="external text external">10.1093/eurheartj/ehp318</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2785945  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2785945'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2785945" class="external text external">2785945</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19690349  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19690349'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19690349" class="external text external">19690349</a>.</cite></span></li></ol></div>

<div role="navigation" class="navbox" aria-labelledby="Antithrombotics_(thrombolytics,_anticoagulants_and_antiplatelet_drugs)_(B01)" style="padding:3px"><table class="nowraplinks hlist mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Antithrombotics_(thrombolytics,_anticoagulants_and_antiplatelet_drugs)_(B01)" style="font-size:114%;margin:0 4em">Antithrombotics (thrombolytics, anticoagulants and antiplatelet drugs) (B01)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Antiplatelet drugs</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Glycoprotein IIb/IIIa inhibitors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Abciximab.htm" tppabs="https://ptable.com/wiki/compounds/A/Abciximab" title="Abciximab">Abciximab</a></li>
<li><a href="Eptifibatide.htm" tppabs="https://ptable.com/wiki/compounds/A/Eptifibatide" title="Eptifibatide">Eptifibatide</a></li>
<li><span class="new">Orbofiban</span></li>
<li><span class="new">Roxifiban</span></li>
<li>Sibrafiban<sup>§</sup></li>
<li><a href="Tirofiban.htm" tppabs="https://ptable.com/wiki/compounds/A/Tirofiban" title="Tirofiban">Tirofiban</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">ADP receptor/P2Y<sub>12</sub> inhibitors</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Thienopyridines
<ul><li><a href="Clopidogrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Clopidogrel" title="Clopidogrel">Clopidogrel</a></li>
<li>Prasugrel</li>
<li><a href="Ticlopidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ticlopidine" title="Ticlopidine">Ticlopidine</a></li></ul></li>
<li>Nucleotide/nucleoside analogs
<ul><li>Cangrelor</li>
<li>Elinogrel</li>
<li>Ticagrelor</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Prostaglandin analogue (<a href="Prostacyclin.htm" tppabs="https://ptable.com/wiki/compounds/A/Prostacyclin" title="Prostacyclin">PGI2</a>)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Beraprost</li>
<li><a href="Iloprost.htm" tppabs="https://ptable.com/wiki/compounds/A/Iloprost" title="Iloprost">Iloprost</a></li>
<li><a href="Prostacyclin.htm" tppabs="https://ptable.com/wiki/compounds/A/Prostacyclin" title="Prostacyclin">Prostacyclin</a></li>
<li><a href="Treprostinil.htm" tppabs="https://ptable.com/wiki/compounds/A/Treprostinil" title="Treprostinil">Treprostinil</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">COX inhibitors</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Aspirin.htm" tppabs="https://ptable.com/wiki/compounds/A/Aspirin" title="Aspirin">Acetylsalicylic acid/Aspirin</a><sup>#</sup></li>
<li>Aloxiprin</li>
<li>Carbasalate calcium</li>
<li>Indobufen</li>
<li>Triflusal</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Thromboxane inhibitors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Thromboxane synthase inhibitors
<ul><li><a href="Dipyridamole.htm" tppabs="https://ptable.com/wiki/compounds/A/Dipyridamole" title="Dipyridamole">Dipyridamole</a> (+ aspirin)</li>
<li><a href="Picotamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Picotamide" title="Picotamide">Picotamide</a></li>
<li>Terbogrel</li></ul></li>
<li>Receptor antagonists
<ul><li>Terbogrel</li>
<li>Terutroban<sup>§</sup></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Phosphodiesterase inhibitors</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Cilostazol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cilostazol" title="Cilostazol">Cilostazol</a></li>
<li><a href="Dipyridamole.htm" tppabs="https://ptable.com/wiki/compounds/A/Dipyridamole" title="Dipyridamole">Dipyridamole</a></li>
<li>Triflusal</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Cloricromen</li>
<li>Ditazole</li>
<li>Vorapaxar</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Anticoagulants</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Vitamin K antagonists<br>(inhibit <a href="Thrombin.htm" tppabs="https://ptable.com/wiki/compounds/A/Thrombin" title="Thrombin">II</a>, VII, IX, X)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Coumarin.htm" tppabs="https://ptable.com/wiki/compounds/A/Coumarin" title="Coumarin">Coumarins</a>: <a href="Acenocoumarol.htm" tppabs="https://ptable.com/wiki/compounds/A/Acenocoumarol" title="Acenocoumarol">Acenocoumarol</a></li>
<li><a href="Coumatetralyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Coumatetralyl" title="Coumatetralyl">Coumatetralyl</a></li>
<li><a href="Dicoumarol.htm" tppabs="https://ptable.com/wiki/compounds/A/Dicoumarol" title="Dicoumarol">Dicoumarol</a></li>
<li>Ethyl biscoumacetate</li>
<li><a href="Phenprocoumon.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenprocoumon" title="Phenprocoumon">Phenprocoumon</a></li>
<li><a href="Warfarin.htm" tppabs="https://ptable.com/wiki/compounds/A/Warfarin" title="Warfarin">Warfarin</a><sup>#</sup></li>
<li><a href="1,3-Indandione.htm" tppabs="https://ptable.com/wiki/compounds/A/1%2C3-Indandione" title="1,3-Indandione">1,3-Indandiones</a>: Clorindione</li>
<li><a href="Diphenadione.htm" tppabs="https://ptable.com/wiki/compounds/A/Diphenadione" title="Diphenadione">Diphenadione</a></li>
<li><a href="Phenindione.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenindione" title="Phenindione">Phenindione</a></li>
<li>Other: Tioclomarol</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Factor Xa inhibitors<br>(with some II inhibition)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Heparin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heparin" title="Heparin">Heparin</a> group/<br>glycosaminoglycans/<br>(bind antithrombin)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Low-molecular-weight heparin
<ul><li>Bemiparin</li>
<li>Certoparin</li>
<li><a href="Dalteparin_sodium.htm" tppabs="https://ptable.com/wiki/compounds/A/Dalteparin_sodium" title="Dalteparin sodium">Dalteparin</a></li>
<li><a href="Enoxaparin_sodium.htm" tppabs="https://ptable.com/wiki/compounds/A/Enoxaparin_sodium" title="Enoxaparin sodium">Enoxaparin</a></li>
<li>Nadroparin</li>
<li>Parnaparin</li>
<li>Reviparin</li>
<li>Tinzaparin</li></ul></li>
<li>Oligosaccharides
<ul><li><a href="Fondaparinux.htm" tppabs="https://ptable.com/wiki/compounds/A/Fondaparinux" title="Fondaparinux">Fondaparinux</a></li>
<li>Idraparinux<sup>§</sup></li></ul></li>
<li>Heparinoids
<ul><li>Danaparoid</li>
<li><a href="Dermatan_sulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Dermatan_sulfate" title="Dermatan sulfate">Dermatan sulfate</a></li>
<li>Sulodexide</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Direct Xa inhibitors ("xabans")</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Apixaban</li>
<li>Betrixaban</li>
<li>Darexaban<sup>§</sup></li>
<li>Edoxaban</li>
<li>Otamixaban<sup>§</sup></li>
<li>Rivaroxaban</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Direct thrombin (IIa) inhibitors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Bivalent: Hirudin
<ul><li><a href="Bivalirudin.htm" tppabs="https://ptable.com/wiki/compounds/A/Bivalirudin" title="Bivalirudin">Bivalirudin</a></li>
<li>Desirudin</li>
<li><a href="Lepirudin.htm" tppabs="https://ptable.com/wiki/compounds/A/Lepirudin" title="Lepirudin">Lepirudin</a></li></ul></li>
<li>Univalent: <a href="Argatroban.htm" tppabs="https://ptable.com/wiki/compounds/A/Argatroban" title="Argatroban">Argatroban</a></li>
<li>Dabigatran</li>
<li><span class="new">Efegatran</span></li>
<li>Inogatran<sup>§</sup></li>
<li><a href="Ximelagatran.htm" tppabs="https://ptable.com/wiki/compounds/A/Melagatran" title="Melagatran" class="mw-redirect">Melagatran</a><sup>‡</sup></li>
<li><a href="Ximelagatran.htm" tppabs="https://ptable.com/wiki/compounds/A/Ximelagatran" title="Ximelagatran">Ximelagatran</a><sup>‡</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Antithrombin III</li>
<li>Defibrotide</li>
<li>Protein C
<ul><li><a href="Drotrecogin_alfa.htm" tppabs="https://ptable.com/wiki/compounds/A/Drotrecogin_alfa" title="Drotrecogin alfa">Drotrecogin alfa</a><sup>‡</sup></li></ul></li>
<li><a href="Ramatroban.htm" tppabs="https://ptable.com/wiki/compounds/A/Ramatroban" title="Ramatroban">Ramatroban</a></li>
<li>REG1</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Thrombolytic drugs/<br>fibrinolytics</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Plasminogen activators: r-tPA
<ul><li>Alteplase</li>
<li><a href="Reteplase.htm" tppabs="https://ptable.com/wiki/compounds/A/Reteplase" title="Reteplase">Reteplase</a></li>
<li><a href="Tenecteplase.htm" tppabs="https://ptable.com/wiki/compounds/A/Tenecteplase" title="Tenecteplase">Tenecteplase</a></li>
<li>Desmoteplase<sup>†</sup></li></ul></li>
<li>UPA
<ul><li>Saruplase</li>
<li><a href="Urokinase.htm" tppabs="https://ptable.com/wiki/compounds/A/Urokinase" title="Urokinase">Urokinase</a></li></ul></li>
<li><a href="Anistreplase.htm" tppabs="https://ptable.com/wiki/compounds/A/Anistreplase" title="Anistreplase">Anistreplase</a></li>
<li>Monteplase</li>
<li><a href="Streptokinase.htm" tppabs="https://ptable.com/wiki/compounds/A/Streptokinase" title="Streptokinase">Streptokinase</a><sup>#</sup></li>
<li>Other serine endopeptidases: Ancrod</li>
<li>Brinase</li>
<li>Fibrinolysin</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Non-medicinal</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Citrate</li>
<li><a href="Ethylenediaminetetraacetic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethylenediaminetetraacetic_acid" title="Ethylenediaminetetraacetic acid">EDTA</a></li>
<li><a href="Oxalate.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxalate" title="Oxalate">Oxalate</a></li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;"><div><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="AstraZeneca" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="AstraZeneca" style="font-size:114%;margin:0 4em">AstraZeneca</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Products</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Anastrozole.htm" tppabs="https://ptable.com/wiki/compounds/A/Anastrozole" title="Anastrozole">Anastrozole</a></li>
<li><a href="Atenolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Atenolol" title="Atenolol">Atenolol</a></li>
<li><a href="Bicalutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bicalutamide" title="Bicalutamide">Bicalutamide</a></li>
<li><a href="Brompheniramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Brompheniramine" title="Brompheniramine">Brompheniramine</a></li>
<li><a href="Budesonide.htm" tppabs="https://ptable.com/wiki/compounds/A/Budesonide" title="Budesonide">Budesonide</a></li>
<li>Disufenton sodium</li>
<li><a href="Esomeprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Esomeprazole" title="Esomeprazole">Esomeprazole</a></li>
<li>FluMist</li>
<li><a href="Fulvestrant.htm" tppabs="https://ptable.com/wiki/compounds/A/Fulvestrant" title="Fulvestrant">Fulvestrant</a></li>
<li><a href="Gefitinib.htm" tppabs="https://ptable.com/wiki/compounds/A/Gefitinib" title="Gefitinib">Gefitinib</a></li>
<li><a href="Goserelin.htm" tppabs="https://ptable.com/wiki/compounds/A/Goserelin" title="Goserelin">Goserelin</a></li>
<li><a href="Isosorbide_mononitrate.htm" tppabs="https://ptable.com/wiki/compounds/A/Isosorbide_mononitrate" title="Isosorbide mononitrate">Isosorbide mononitrate</a></li>
<li>Motavizumab</li>
<li><a href="Omeprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Omeprazole" title="Omeprazole">Omeprazole</a></li>
<li>Palivizumab</li>
<li><a href="Propofol.htm" tppabs="https://ptable.com/wiki/compounds/A/Propofol" title="Propofol">Propofol</a></li>
<li><a href="Rosuvastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Rosuvastatin" title="Rosuvastatin">Rosuvastatin</a></li>
<li><a href="Tamoxifen.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamoxifen" title="Tamoxifen">Tamoxifen</a></li>
<li>Ticagrelor</li>
<li>Vandetanib</li>
<li><a href="Ximelagatran.htm" tppabs="https://ptable.com/wiki/compounds/A/Ximelagatran" title="Ximelagatran">Ximelagatran</a></li>
<li><a href="Zafirlukast.htm" tppabs="https://ptable.com/wiki/compounds/A/Zafirlukast" title="Zafirlukast">Zafirlukast</a></li>
<li><a href="Zolmitriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Zolmitriptan" title="Zolmitriptan">Zolmitriptan</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Predecessors and<br>acquired companies</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Astra AB</li>
<li>Cambridge Antibody Technology</li>
<li>MedImmune</li>
<li>Zeneca</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">People</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Tom McKillop</li>
<li>Louis Schweitzer</li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="font-weight: bold;"><div>
<ul><li><figure-inline><span><img src="../I/m/Folder_Hexagonal_Icon.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Folder_Hexagonal_Icon.svg.png" data-file-width="36" data-file-height="31" data-file-type="drawing" height="14" width="16"></span></figure-inline> Category</li>
<li><figure-inline><span><img src="../I/m/Commons-logo.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Commons-logo.svg.png" data-file-width="1024" data-file-height="1376" data-file-type="drawing" height="16" width="12"></span></figure-inline> <a href="javascript:if(confirm('https://commons.wikimedia.org/wiki/Category:AstraZeneca  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://commons.wikimedia.org/wiki/Category:AstraZeneca'" tppabs="https://commons.wikimedia.org/wiki/Category:AstraZeneca" title="commons:Category:AstraZeneca" class="external">Commons</a></li></ul>
</div></td></tr></tbody></table></div>






<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-04-17" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Ximelagatran&oldid=951471448  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Ximelagatran&oldid=951471448'" tppabs="https://en.wikipedia.org/wiki/?title=Ximelagatran&oldid=951471448">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>